Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

NIVF NewGenIvf Group Limited Class A ordinary shares
$0.17 -15.71% -0.03
Notify me if price changes either direction
Interactive Brokers Logotype

Buy NIVF stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades

NewGenIvf Group Limited Class A ordinary shares (NIVF)

Loading

Key Stats

Market cap. 276.2K
Enterprise value -3488229
Trailing PE 0.00030062135
Forward PE 8.595049E-5
PEG Ratio 8.595049E-5
Enterprise to EBITDA 0.326
Enterprise to revenue -0.753
Price to book MRQ 0.0003150937
Price to sales TTM 0.07977829

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2025-12-31
Revenue (TTM) 4.6M
EBITDA -10690328
Diluted EPS TTM -34064.71
Total Cash (MRQ) 4.4M
Current ratio (MRQ) 1.059
Operating Cash Flow (TTM) -14638438

NIVF trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent NIVF News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.